ARCHIVES

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 17 | May 2, 2008

Download PDF Visit The Full Archive

Related Articles

In the cancer centers: San Antonio Cancer Institute gets a new director, funding commitments.

March 12, 2004

On Capitol Hill: Cancer Organizations Push Congress For Payment Of Patient Care Costs In Trials

September 17, 1999

ASCO Updates Guideline On Antiemetics

June 30, 2006

Major League Baseball Begins Struggle to Eject Ever-Present Smokeless Tobacco Forom The Sport

April 12, 1991

NCI to Study Review Group’s report Urging Restructure of Prevention Programm

June 27, 1997

NCI Largely Unaffected By NIH Translational Research Center

February 11, 2011